在非小细胞肺癌中SLC7A11和NLRP1
Abida Khan1, Abdullah R Alzahrani2, Talha Jawaid3
1Center For Health Research, Northern Border University, Arar 73213, Saudi Arabia.
Clinica chimica acta; international journal of clinical chemistry
|November 5, 2025
概括
本综述评估了非小细胞肺癌 (NSCLC) 的SLC7A11和NLRP1生物标志物. 标准化的预分析控制和测试对于这些NSCLC生物标志物的可靠临床使用至关重要.
科学领域:
- 生物标志物的发现和验证.
- 临床实验室科学 临床实验室科学
- 分子诊断学 分子诊断学
背景情况:
- 非小细胞肺癌 (NSCLC) 需要强大的生物标志物来诊断,预后和治疗监测.
- SLC7A11 (溶体载体家族7成员11) 和NLRP1 (NOD类受体家族pyrin域含1) 是具有潜在临床实用性的新兴标记物.
- 目前的研究在交叉研究比较方面存在挑战,原因是方法上的差异.
研究的目的:
- 批判性地评估SLC7A11和NLRP1作为NSCLC的临床实验室生物标志物.
- 定义这些生物标志物的分析前控制,试验选择/验证标准,以及决策用例.
- 评估SLC7A11和NLRP1在NSCLC管理中的准备和实用性.
主要方法:
- 对NSCLC中SLC7A11和NLRP1的现有文献的审查.
- 对每个标记物进行样本处理和储存的预分析要求的分析.
- 定义分析性能目标,包括准确性,精度,检测极限和质量评估.
主要成果:
- 提供了具体的预分析建议:用于SLC7A11 (液体活检) 的酸盐血和用于NLRP1 (蛋白质/细胞因子) 的肝素血/血清.
- 定义的分析目标:准确度为85-115%,CV<15%,建立了LOD/LLOQ,并参与了EQA.
- 强调需要标准化报告以促进临床验证.
结论:
- 标准化的预分析处理和验证的试验对于SLC7A11和NLRP1在NSCLC的可靠临床应用至关重要.
- 遵守推的协议将提高生物标志物的性能,加速临床决策.
- 进一步规范报告将加速将这些生物标志物整合到NSCLC诊断和治疗策略中.
更多相关视频
10:29Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
Published on: August 14, 2019
11.0K
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
714
相关概念视频
lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
